VerifyNow in acute coronary syndrome: design of the EPIC17-VERONICA trial to optimize platelet inhibition.

Garilleti Cámara C, de la Torre-Hernández JM, Rumoroso Cuevas JR, Romaní S, Monastyrski AV, Nieto AD, Bayón Lorenzo J, Cubero Gallego H, Gómez-Hospital JA, Vallejo Calcerrada N, Pérez Guerrero A, Amat-Santos IJ, Alcalde Martínez V, López-Palop R, Jimeno Sánchez J, Pérez de Prado A, Lozano Martínez-Luengas Í

Open source

DOI: 10.24875/recice.m25000544
Published: 2026 Apr-Jun
Container: REC, interventional cardiology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.24875/recice.m25000544,
  title = {VerifyNow in acute coronary syndrome: design of the EPIC17-VERONICA trial to optimize platelet inhibition.},
  author = {Garilleti Cámara C and de la Torre-Hernández JM and Rumoroso Cuevas JR and Romaní S and Monastyrski AV and Nieto AD and Bayón Lorenzo J and Cubero Gallego H and Gómez-Hospital JA and Vallejo Calcerrada N and Pérez Guerrero A and Amat-Santos IJ and Alcalde Martínez V and López-Palop R and Jimeno Sánchez J and Pérez de Prado A and Lozano Martínez-Luengas Í},
  year = {2026},
  journal = {REC, interventional cardiology},
  doi = {10.24875/recice.m25000544},
  url = {https://doi.org/10.24875/recice.m25000544}
}

RIS

TY  - JOUR
TI  - VerifyNow in acute coronary syndrome: design of the EPIC17-VERONICA trial to optimize platelet inhibition.
AU  - Garilleti Cámara C
AU  - de la Torre-Hernández JM
AU  - Rumoroso Cuevas JR
AU  - Romaní S
AU  - Monastyrski AV
AU  - Nieto AD
AU  - Bayón Lorenzo J
AU  - Cubero Gallego H
AU  - Gómez-Hospital JA
AU  - Vallejo Calcerrada N
AU  - Pérez Guerrero A
AU  - Amat-Santos IJ
AU  - Alcalde Martínez V
AU  - López-Palop R
AU  - Jimeno Sánchez J
AU  - Pérez de Prado A
AU  - Lozano Martínez-Luengas Í
PY  - 2026
JO  - REC, interventional cardiology
DO  - 10.24875/recice.m25000544
UR  - https://doi.org/10.24875/recice.m25000544
ER  -

APA

C, G. C., JM, D. L. T., JR, R. C., S, R., AV, M., AD, N., J, B. L., H, C. G., JA, G., N, V. C., A, P. G., IJ, A., V, A. M., R, L., J, J. S., A, P. D. P., & Í, L. M. (2026). VerifyNow in acute coronary syndrome: design of the EPIC17-VERONICA trial to optimize platelet inhibition.. REC, interventional cardiology. https://doi.org/10.24875/recice.m25000544

Source records

pubmed · retrieved 2026-09-25T07:06:59.859Z